"Brain Stem Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.
| Descriptor ID |
D020295
|
| MeSH Number(s) |
C04.588.614.250.195.411.100 C10.228.140.211.500.100 C10.551.240.250.400.200
|
| Concept/Terms |
Brain Stem Neoplasms- Brain Stem Neoplasms
- Brain Stem Neoplasm
- Neoplasm, Brain Stem
- Neoplasms, Brain Stem
- Brainstem Neoplasms
- Brainstem Neoplasm
- Neoplasm, Brainstem
- Brainstem Tumors
- Brainstem Tumor
- Neoplasms, Brainstem
- Brain Stem Tumors
- Brain Stem Tumor
- Tumor, Brain Stem
Pontine Tumors- Pontine Tumors
- Pontine Tumor
- Tumor, Pontine
- Tumors, Pontine
- Pontine Neoplasms
- Neoplasms, Pontine
- Neoplasm, Pontine
- Pontine Neoplasm
Mesencephalic Neoplasms- Mesencephalic Neoplasms
- Mesencephalic Neoplasm
- Neoplasm, Mesencephalic
- Neoplasms, Midbrain
- Midbrain Tumors
- Midbrain Tumor
- Tumor, Midbrain
- Tumors, Midbrain
- Midbrain Neoplasms
- Midbrain Neoplasm
- Neoplasm, Midbrain
- Neoplasms, Mesencephalic
Brain Stem Neoplasms, Primary- Brain Stem Neoplasms, Primary
- Primary Brainstem Neoplasms
- Primary Brain Stem Neoplasms
- Brainstem Neoplasms, Primary
- Brainstem Neoplasm, Primary
- Neoplasm, Primary Brainstem
- Neoplasms, Primary Brainstem
- Primary Brainstem Neoplasm
- Neoplasms, Brainstem, Primary
Medullary Neoplasms- Medullary Neoplasms
- Medullary Neoplasm
- Neoplasm, Medullary
- Neoplasms, Medullary
- Medullary Tumors
- Medullary Tumor
- Tumor, Medullary
- Tumors, Medullary
|
Below are MeSH descriptors whose meaning is more general than "Brain Stem Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Brain Stem Neoplasms".
This graph shows the total number of publications written about "Brain Stem Neoplasms" by people in this website by year, and whether "Brain Stem Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 5 | 0 | 5 |
| 2021 | 1 | 0 | 1 |
| 2022 | 4 | 0 | 4 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Brain Stem Neoplasms" by people in Profiles.
-
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas. Nature. 2025 01; 637(8046):708-715.
-
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). Neuro Oncol. 2023 12 08; 25(12):2262-2272.
-
Immunotherapy approaches for the treatment of diffuse midline gliomas. Oncoimmunology. 2022; 11(1):2124058.
-
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report. Neuro Oncol. 2022 04 01; 24(4):655-664.
-
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature. 2022 03; 603(7903):934-941.
-
Characteristics of patients =10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry. Neuro Oncol. 2022 01 05; 24(1):141-152.
-
Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasion. Brain Res. 2021 07 01; 1762:147348.
-
A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas. J Neurooncol. 2020 Sep; 149(3):437-445.
-
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Neuro Oncol. 2020 06 09; 22(6):875-885.
-
Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol. 2020 06; 21(6):e330-e336.